Abstract
Chronically implanted devices depending on polymers have contributed significantly to improving the quality of life for many people. Examples of such devices include joint prostheses, cardiac pacemakers, arteriovenous shunts for dialysis, vascular grafts, cerebrospinal fluid (CSF) shunts, urethral catheters, sutures, mammary prostheses, dental prostheses, heart valves, neural stimulators, and implantable defibrillators. Some of the more common examples of polymers generally considered to be implantable and biostable include polyethylene, polypropylene, polyether polyurethanes, (aromatic) polyesters, silicone rubbers, hydrogels (poly HEMA), (solid) acrylics, and fluoro polymers (such as teflon). Many other polymers have physical properties that are very desirable for use in implanted devices, but their biostability is controversial or limits them to use in relatively short-term implants. The polyamides (nylons) and (aliphatic) polyester polyurethanes are examples. Certainly there are implantable devices that are intentionally designed to biodegrade, such as tissue scaffolds. The purpose of this chapter, however, is to review the failure mechanisms that can affect biostable polymers: those polymers that are intended to maintain properties adequate to facilitate the long-term performance of implanted devices. In addition, this chapter will review some of the test methodology needed to qualify a biostable polymer for human use.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.